After a big run like this, all of these low floats end up in the tank. Just speculating that this will follow tradition.
Extremely overbought. We are leaning towards selling. What do you think?
$SMMT insider ownership is crazy high and the CEO owns 162+ Mil shares by himself, that’s crazy confidence! Insider Ownership 82% cdn.discordapp.com media.discordapp.net www.sec.gov NASDAQ:SMMT
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that...
Breaking Key area, and Also major resistance and can go back to down side to the consolidation zone. signs look bullish, but a key area to watch. Have a Happy Day
Reversal on the 4 hour, from a huge drop in Dec due to poor results for their trials when they combined data. They said 2022 end of 1st quarter they will release an update. They stopped the offering to investors and will give an update later.
This may be catching a falling knife, but I found SMMT on my scanner after it was down 50% in a day If you look at all the analyst ratings on this stock there's no reason it should be down where it is right now. It's down to $2.44 right now at it's 52 week low when just weeks ago it was worth $12 a share. This is a bargain, it's fallen hard before but there's good...
Contextual immersion trading strategy idea. Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States, Latin America, and Europe. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the...
Small company, but Duggan Robert W just purchased $46,999,999
Contextual immersion trading strategy idea. Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States, Latin America, and Europe. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the...
There was a suggestion that the pharmaceutical outsourcing in America is coming back to America so there is 90% up for grabs and they have a good opportunity, also looks like a hammer on the one amateur one hour chart , I could just be hopeful do not copy but feel free to comment .
I bought this asset yesterday - not quite perfect cup and handle, but really nice looking. Now approaching 10 week average. Fundamentals looking great. +250% growth in rev YoY EPS YTY from (0.40) to 0.12 I see big potential in this one. This is no trading advice - just an idea I'd like to share with you.
An easy win above 2.87 SMMT is gaining speed and with a positive catalyst and traction will continue strong. Like many of these stocks in this setup, we are seeing high loading volume with an increased potential for a breakout as the price increases.
Fibonacci gives me an idea of how this stock will behave. Along with the Volume MA and other indicator such us the bottom plots, I believe this stock is forecasted to go down for a few days before it goes back up. Wait for future indicators and to be below 10.3$ to enter (if you want to be conservative). Also, keep an eye open for news. This stock is fairly new...